Inner Cosmos LLC

Inner Cosmos LLC specializes in innovative neurotechnology solutions that enhance mental health and cognitive performance through advanced neurostimulation. The company targets healthcare providers and individuals seeking cognitive enhancement. Founded in 2016 and headquartered in New Haven, US, Inner Cosmos LLC focuses on developing neurotechnology solutions. The firm has completed 4 deals, with their most recent funding round in March 2022 where they raised USD 10.

00 mn in Seed funding led by lool ventures, with participation from Deepwater Asset Management and KittyHawk Ventures. The founders include Abby Rieb, Daniel Moran, Erling Hyldgaard, Meron Gribetz, Satish D, and Theodore Kucklick, while Meron Gribetz serves as the CEO. Inner Cosmos focuses on the development and commercialization of innovative neurotechnology solutions designed to enhance mental health and cognitive performance. Their flagship product leverages advanced neurostimulation techniques to address various issues, including anxiety, depression, and cognitive decline.

By utilizing non-invasive methods, the product aims to improve emotional well-being and cognitive capabilities among users. The company targets a diverse clientele, including healthcare providers, mental health professionals, and individuals seeking to optimize their mental performance, primarily serving markets in North America and Europe. Inner Cosmos generates revenue through a direct-to-consumer model, offering subscription-based access to its neurostimulation products. Clients can purchase individual devices or opt for subscription plans that provide ongoing access to software updates and additional features.

The company’s pricing structure includes a one-time cost for the initial product purchase, followed by recurring fees for access to premium content and services. This approach facilitates a steady revenue stream while fostering customer loyalty and engagement. By partnering with healthcare providers and mental wellness practitioners, Inner Cosmos enhances its market reach and diversifies its revenue channels, creating a robust framework for financial growth. In March 2022, Inner Cosmos LLC raised USD 10.

00 mn in Seed funding to support its platform development and future growth expansion plans. The company intends to leverage these funds to design and launch new neurotechnology products aimed at addressing a broader range of mental health issues, with specific release dates to be announced. Additionally, Inner Cosmos plans to expand its market presence in Europe and North America by the end of 2023.